BridgeMD
Compares treatment options for Plantar Fasciitis
Official title Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Chronic Plantar Fasciitis
ClinicalTrials.gov ID: NCT07242729
What this study is testing
What is Bone Marrow Aspirate Injection?
Bone Marrow Aspirate Injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for plantar fasciitis.
Also referred to as BMA.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This randomized, double-blind clinical trial aims to compare the clinical and imaging effects of autologous bone marrow aspirate versus platelet-rich fibrin injections in patients with chronic plantar fasciitis. The procedures are performed under ultrasound guidance to ensure precision and safety.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Adults aged 18 to 75 years.
- Clinical diagnosis of chronic plantar fasciitis for more than 6 months, confirmed by ultrasonography (increased plantar fascia thickness and...
- Persistent heel pain refractory to conventional conservative treatment (stretching, orthotics, physical therapy, or corticosteroid injections).
- Visual Analog Scale (VAS) pain score ≥ 4 at baseline.
- Ability and willingness to comply with study procedures and follow-up assessments.
You likely can't join if
- Previous foot or ankle surgery on the affected limb.
- Acute trauma, infection, or ulceration in the region of the plantar fascia.
- Systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus, psoriatic arthritis).
- Metabolic or endocrine disorders interfering with healing (e.g., diabetes mellitus with poor glycemic control, thyroid disorders).
- Current use of systemic corticosteroids, immunosuppressants, or anticoagulants.
- Active neoplasia or hematologic disorders.
See the full eligibility criteria
- Adults aged 18 to 75 years.
- Clinical diagnosis of chronic plantar fasciitis for more than 6 months, confirmed by ultrasonography (increased plantar fascia thickness and hypoechogenicity).
- Persistent heel pain refractory to conventional conservative treatment (stretching, orthotics, physical therapy, or corticosteroid injections).
- Visual Analog Scale (VAS) pain score ≥ 4 at baseline.
- Ability and willingness to comply with study procedures and follow-up assessments.
- Signed informed consent.
- Previous foot or ankle surgery on the affected limb.
- Acute trauma, infection, or ulceration in the region of the plantar fascia.
- Systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus, psoriatic arthritis).
- Metabolic or endocrine disorders interfering with healing (e.g., diabetes mellitus with poor glycemic control, thyroid disorders).
- Current use of systemic corticosteroids, immunosuppressants, or anticoagulants.
- Active neoplasia or hematologic disorders.
- Pregnancy or breastfeeding.
- Peripheral vascular disease or neuropathy affecting the lower limbs.
- Contraindications to local anesthesia or venipuncture.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.